The next focusIR Investor Webinar takes places on 14th May with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMorgan Advanced Materials Regulatory News (MGAM)

Share Price Information for Morgan Advanced Materials (MGAM)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 326.50
Bid: 325.00
Ask: 326.00
Change: 3.50 (1.08%)
Spread: 1.00 (0.308%)
Open: 328.50
High: 329.50
Low: 322.50
Prev. Close: 323.00
MGAM Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Capital Markets Event

6 Dec 2022 07:00

RNS Number : 6717I
Morgan Advanced Materials PLC
06 December 2022
 

Press Release

Morgan Advanced Materials plc

6 December 2022

 

Capital Markets Event

"Delivering resilient, scalable growth"

Morgan Advanced Materials plc will hold a Capital Markets Event this afternoon at the Science Museum in London.

The event will include a series of presentations by our senior leadership team, which will focus on our opportunities for profitable growth as a global manufacturer of advanced carbon and ceramic materials for complex and technologically demanding applications. These include specific initiatives to drive sustainable growth through the industrial cycle.

We also set out the following through the cycle financial objectives:

- Accelerating Organic Revenue Growth. Extending our position in faster growing markets, supporting 3-6% p.a.

- Attractive Margins. 12.5% - 15% adjusted operating profit margin

- Delivering EPS Growth.  Achieving enhanced growth in adjusted Earnings per Share, ahead of organic revenue growth, driven by a combination of organic growth, inorganic activity and shareholder returns

- Leverage Range. 1.0x to 2.0x adjusted EBITDA

- Sustaining ROIC. 17 - 20% ROIC

In addition, we set out the following capital allocation policies:

- Focussing Organic Investment.  Investment to enhance growth and returns, including an additional £60m of capital in our Semiconductor manufacturing capacity over the next few years

- Enhancing Regular Returns via a Progressive Dividend Policy. Grow the regular dividend through the cycle with an adjusted earnings cover of c.2.5x

- Inorganic Activity. Complementary, disciplined M&A focused on accelerating revenue growth opportunities in faster growing markets

- Additional Returns. Additional returns of surplus capital to shareholders as appropriate.

The presentation for the event will be made available at www.morganadvancedmaterials.com at 14:00 UK time today. A recording of the presentation will be made available following the event.

Accelerated Pension Contribution

We have agreed with the Trustees of our UK Defined Benefit Pension Schemes a contribution of £67m that will create further balance sheet flexibility whilst substantially reducing future cash contributions. Further detail is provided in a separate RNS released today.

RCF Renewal

We have secured a new five-year Revolving Credit Facility of £230m that replaces our existing RCF that was due to mature in 2023.

FY22 Guidance

Our outlook and guidance for full year 2022 provided in our Trading Update of 4 November 2022 remain unchanged.

 

For further enquiries:

Pete Raby, CEO

Morgan Advanced Materials plc

01753 837000

Richard Armitage, CFO

Nina Coad

Brunswick

0207 404 5959

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCUVSWRUBUURAA
Date   Source Headline
10th May 20197:00 amRNSTrading Update
7th May 20194:36 pmRNSDirectorate Change
8th Apr 20195:29 pmRNSDirector/PDMR Shareholding
3rd Apr 201911:22 amRNSAnnual Financial Report
19th Mar 20199:47 amRNSDirector/PDMR Shareholding
19th Mar 20199:44 amRNSDirector/PDMR Shareholding
26th Feb 20197:00 amRNSFinal Results
17th Dec 201810:51 amRNSBlock listing Interim Review
21st Nov 20182:36 pmRNSDirector/PDMR Shareholding
21st Nov 20187:00 amRNSDivestment of Composites and Defence Systems
9th Nov 20187:00 amRNSTrading Update
22nd Oct 20185:17 pmRNSHolding(s) in Company
28th Sep 20188:17 amRNSCompletion of Bank Refinancing
6th Aug 20189:24 amRNSDirector/PDMR Shareholding
1st Aug 20188:54 amRNSDirector/PDMR Shareholding
26th Jul 20187:00 amRNSHalf-year results
2nd Jul 20182:37 pmRNS2017 Environmental, Health and Safety Report
2nd Jul 20187:00 amRNSDirectorate Change
15th Jun 20189:00 amRNSBlock listing Interim Review
11th May 20181:32 pmRNSResult of AGM
1st May 20182:08 pmRNSDirector/PDMR Shareholding
23rd Apr 20187:00 amRNSQ1 Trading Update
10th Apr 20183:31 pmRNSAnnual Financial Report
29th Mar 20183:47 pmRNSHolding(s) in Company
21st Mar 20184:26 pmRNSDirector/PDMR Shareholding
21st Mar 20184:12 pmRNSDirector/PDMR Shareholding
21st Mar 201810:04 amRNSHolding(s) in Company
2nd Mar 201811:22 amRNSHolding(s) in Company
1st Mar 201811:31 amRNSDirector/PDMR Shareholding
27th Feb 20187:00 amRNSFull-year results for period ended 31 Dec 2017
24th Jan 20187:00 amRNSUS tax reform
2nd Jan 201810:32 amRNSDirector/PDMR Shareholding
15th Dec 20178:00 amRNSBlock listing Interim Review
11th Dec 20177:00 amRNSAdditional US pension payment
8th Dec 20172:22 pmRNSChange of Senior Independent Director
27th Nov 201710:29 amRNSHolding(s) in Company
6th Nov 20177:00 amRNSTrading update
26th Sep 201710:39 amRNSDirector/PDMR Shareholding
22nd Sep 20175:03 pmRNSDirector/PDMR Shareholding
5th Sep 201711:13 amRNSDirector/PDMR Shareholding
4th Sep 201712:09 pmRNSDirector/PDMR Shareholding
30th Aug 201712:31 pmRNSHolding(s) in Company
28th Jul 20177:00 amRNSHALF YEAR RESULTS FOR 6 MONTHS ENDED 30 JUNE 2017
24th Jul 201711:53 amRNSHalf year results notification
6th Jul 20173:44 pmRNSHolding(s) in Company
15th Jun 20179:39 amRNSBlock listing Interim Review
5th May 20171:52 pmRNSResult of AGM
5th May 20177:00 amRNSTrading Statement
28th Apr 20179:36 amRNSAppointment of Non-Executive Director
12th Apr 201710:53 amRNS2016 Environmental, Health and Safety Report

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.